Please login to the form below

Not currently logged in

Novo Nordisk gets FDA nod for once-weekly rival to Lilly’s Trulicity

GLP-1 agonist Ozempic approved in the US for type 2 diabetes

UK trumpets life sciences post-Brexit ‘sector deal’

Brexit UK EU life sciences pharma biotechHighlights commitments from GlaxoSmithKline, AstraZeneca and MSD

Amgen gets prevention claim for cholesterol drug Repatha

Amgen Repatha evolocumabFDA approves new labelling on heart attack and stroke risk reduction

Mylan gets first biosimilar Herceptin OK from FDA

MylanOgivri approved by US regulators for all of Roche blockbuster's indications

NICE set to reject wider use of Eisai’s Halaven

Eisai cancer drug Halaven eribulinIssues draft guidance recommending against second-line use in breast cancer

Janssen’s Tremfya cleared for European use

EU flagEC approves the medicine to treat adults with plaque psoriasis

EC expands Janssen’s prostate cancer drug reach

Janssen logoZytiga plus predinson/prednisolone will now treat mHSPC patients

GSK’s ViiV gets US okay for two-drug HIV regimen

ViiV HealthcareJuluca is a combination of ViiV’s Tivicay and Janssen’s Edurant

KeysMoving times

Continuity and stability are vital when it comes to the EMA's relocation when it leaves London

Latest regulatory appointments

Featured jobs

Subscribe to our email news alerts


Add my company

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

Grabbing your audience*
Highlighting one of our recent pieces of work - a powerful disease awareness film created in partnership with Watchable Films...
Defining Market Access and the Key to Success
Kevin Lennon, Head of Operations & Market Access at OUTiCO, shares his definition of market access and the key to success....
“My sister went without treatment despite relapses - enough was enough, I had to intervene”...